Clinical relevance of intratumoural immune cell composition in non-small cell lung cancer.

被引：0
|
作者：
Li, Xuetao
Zhang, Jia-Tao
Su, Jian
Yang, Jinji
Zhong, Wenzhao
Zhang, Xuchao
Wu, Yi-Long
Hou, Jun
机构：
[1] South China Univ Technol, Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou 510080, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Key Lab Lung Canc Translat Med, Guangzhou 510080, Peoples R China
[3] Guangdong Gen Hosp & Guangdong Acad Med Sci, Guangdong Prov Key Lab Translat Med Lung Canc, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[4] Guangdong Gen Hosp & Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[5] South China Univ Technol, Sch Med, Guangzhou 510006, Guangdong, Peoples R China
[6] Univ Med Ctr Rotterdam, Dept Hepatol, Erasmus MC, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.8547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8547
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical relevance of intraoperative pleural lavage cytology in non-small cell lung cancer
    Nakagawa, Tatsuo
    Okumura, Norihito
    Kokado, Yujiro
    Miyoshi, Kentaroh
    Matsuoka, Tomoaki
    Kameyama, Kotaro
    [J]. ANNALS OF THORACIC SURGERY, 2007, 83 (01): : 204 - 208
  • [32] Myeloid Derived Supressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer
    Arrieta Rodriguez, Oscar
    Morales-Flores, Renato
    Garcia-Vicente, Angeles
    Montes-Servin, Edgar
    Salinas-Parra, Fernanda
    Barrera, Lourdes
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S255 - S255
  • [33] Trends in ALK inhibitors for non-small cell lung cancer.
    Meade, Denise
    Ng, Marie
    Alford, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Immune microenvironment composition in non-small cell lung cancer and its association with survival
    Tamminga, Menno
    Hiltermann, Thijo Jeroen N.
    Schuuring, Ed
    Timens, Wim
    Fehrmann, Rudolf S. N.
    Groen, Harry J. M.
    [J]. CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (06)
  • [35] Prognostic relevance of 46 clinical, "classical" laboratory and oncological parameters in patients with advanced non-small cell lung cancer.
    Holden-rieder, S
    von Pawel, J
    Heinemann, V
    Raith, H
    Feldmann, K
    Stenman, UH
    Nagel, D
    Stieber, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 669S - 669S
  • [36] Immunological markers of outcome of non-small cell lung cancer.
    Potter, DA
    Amin, C
    Mohiuddin, A
    Badve, S
    Davidson, D
    Kesler, K
    Hanna, N
    Edenberg, H
    Einhorn, L
    Mitra, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 678S - 678S
  • [37] Association of brain metastasis in non-small cell lung cancer.
    Zhao, Yu
    Guo, Huiqin
    Lu, Jiangyang
    Christiani, David C.
    Lin, Xihong
    Wang, Zhaoxi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Tertiary Lymphoid Structures, Immune Response, and Prognostic Relevance in Non-Small Cell Lung Cancer
    Giatromanolaki, Alexandra
    Chatzipantelis, Paschalis
    Contrafouris, Constantinos A.
    Koukourakis, Michael, I
    [J]. CANCER INVESTIGATION, 2023, 41 (01) : 48 - 57
  • [39] Using a multiplexed immunofluorescence approach to compare immune cell populations in subtypes of non-small cell lung cancer.
    Juncker-Jensen, Anna
    Reddy, Vivek
    Parnell, Erinn
    Nagy, Mate Levente
    Kuo, Judy
    Leones, Eric
    Sahafi, Flora
    Hoe, Nicholas
    William, Josette
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Minority patients in clinical trials (CT) for advanced non-small cell lung cancer.
    Obasaju, CK
    Catalano, RB
    Marinucci, DM
    Bloss, JD
    Taylor, L
    Monberg, MJ
    Comis, RL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 658S - 658S
12345